VytronUS
Manufacturing · California, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
658 N Pastoria Ave, Sunnyvale, Californi...Phone Number
(408) 730-1333Website
www.vytronus.comRevenue
$13.5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About VytronUS
Headquartered in California's Silicon Valley, Vytronus, Inc. was formed in 2006 to harness the imaging and therapeutic capabilities of ultrasound energy to treat cardiac arrhythmias, starting with atrial fibrillation. The company believes that a new energy source, such as collimated ultrasound, is amenable to automation and capable of both imaging and ablating, thus shifting the treatment paradigm to more predictable outcomes. The company strives to make a complicated procedure simple. Ease of use guides every aspect of the company's design philosophy. At Vytronus, patient safety is always the company's first priority and improved efficacy is the company's mission. The company look forward to obtaining regulatory approvals and making the company's products available to doctors and their patients in the near future.Explore more
VytronUS Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is VytronUS your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if VytronUS has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if VytronUS had a recent Job posting/layoffs
Check out if VytronUS is spiking on competitors!
Earning: See what the market has to say on VytronUS recently announced quarterly report
Funding: Get notified immidiatlly once VytronUS has new funding data
Product Launch: Get notified when VytronUS launches new products
VytronUS, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at VytronUS
Website visits: Recent activity has been detected on your website
Recommended Actions
Find VP level buyers at VytronUS
Find 2 more new buyers
Compare Similar Companies to VytronUS
Compare insights from companies similar to VytronUS, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
VytronUS is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
VytronUS is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about VytronUS.
VytronUS financials insights
Gather financial insights about VytronUS, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2007
Series A
$6.6M
2009
Private Equity
$11M
2011
Debt
$5.7M
2012
Debt
$8.7M
2014
Series B
$7.8M
VytronUS Tech Stack
A closer look at the technologies used by VytronUS
VytronUS News & Media
Vytronus to Demonstrate Automated Ultrasound Technology in Clinical Development for the Treatment of Atrial Fibrillation
Booth #2427 at Heart Rhythm 2019, in San Francisco from May 8–11, represents first time Bay Area med-tech start-up will exhibit at major medical meeting for electrophysiologists SUNNYVALE, Calif., May 6, 2019 /PRNewswire/ -- Vytronus, Inc., a privately held medical device company...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding VytronUS
Sign Up For FreeTo access detailed company insights
Headquartered in California's Silicon Valley, Vytronus, Inc. was formed in 2006 to harness the imaging and therapeutic capabilities of ultrasound energy to treat cardiac arrhythmias, starting with atrial fibrillation. The company believes that a new energy source, such as collimated ultrasound, is amenable to automation and capable of both imaging... Read More
